类固醇使用与实体瘤患者生存的关联:系统综述与荟萃分析
结果显示类固醇使用与总生存期缩短(HR=1.18,95%CI 1.1-1.26;肺癌、晚期疾病及支持治疗适应症患者死亡风险增加更明显。
要点
- 实体瘤患者使用类固醇与总生存期和无进展生存期缩短相关。
- 肺癌、晚期疾病及支持/姑息治疗适应症中类固醇增加死亡风险。
- 晚期癌症患者应减少或避免使用类固醇,尤其肺癌和姑息支持治疗。
核心结论
- 在晚期实体瘤患者中,使用类固醇可能降低生存,尤其肺癌及姑息/支持治疗患者,应减少或避免使用。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、EMBASE和Cochrane Library从建库至2020年6月发表的文献。
主要发现
- 在肺癌、晚期疾病及支持治疗适应症患者中,类固醇使用增加死亡风险。
临床怎么用
- 对晚期实体瘤患者,尤其肺癌及姑息/支持治疗者,应审慎评估类固醇使用,尽量减少或避免。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Steroids are commonly used in patients with solid tumours for supportive therapy. In other cases, they are an essential part of cancer treatment such as prostate cancer. Some preclinical observations lead to the notion that glucocorticoids may modulate growth factors' pathways and may induce the progression of cancers. Glucocorticoids are associated with several side-effects on many organ systems (e.g. serious infections, diabetes, sepsis and thrombosis). We have performed a systematic review and meta-analysis to evaluate the outcome of cancer patients that assume or not steroids. METHODS: Published articles that evaluated survival associated with steroids use in cancer patients from inception to June 2020 were identified by searching the PubMed, EMBASE and Cochrane Library databases. The primary outcome of interest was the risk of death, and the secondary end-point was the risk of progression in steroid versus non-steroid users. RESULTS: Seventy-six studies were in quantitative synthesis for a total of 83,614 patients. Use of steroids was associated with a reduced survival (hazard ratios (HR) = 1.18, 95% confidence interval (CI): 1.1-1.26; P < .01). Progression-free survival was also decreased in steroid versus non-steroid users (HR = 1.13, 95% CI: 1.01-1.26; P = .03). In patients with lung cancer, advanced disease and supportive care indications were settings where the use of steroids increased the risk of death. CONCLUSIONS: In patients with advanced cancers, use of steroids should be reduced and, at best, avoided because it may reduce survival, in particular, for patients with lung cancer and for palliative/supportive care purposes.
引用
- Petrelli F, Bukovec R, Perego G, et al. Association of steroid use with survival in solid tumours. Eur J Cancer. 2020. PMID: 33130548. doi:10.1016/j.ejca.2020.09.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。